{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:41:43Z","timestamp":1767148903874,"version":"build-2238731810"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":11574,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1988]]},"DOI":"10.1016\/s0021-5198(19)43207-1","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:41:36Z","timestamp":1605656496000},"page":"237-243","source":"Crossref","is-referenced-by-count":46,"title":["[3H]GBR-12935 Binding Sites in Human Striatal Membranes: Binding Characteristics and Changes in Parkinsonians and Schizophrenics"],"prefix":"10.1016","volume":"47","author":[{"given":"Midori","family":"HIRAI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"KITAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"HASHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"NAKAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"MITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"SHIRAKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"YAMADORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"AMANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadako A.","family":"NOGUCHI-KUNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0021-5198(19)43207-1_bib1","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/0006-2952(74)90250-0","article-title":"Uptake mechanisms for neurotransmitter amines","volume":"23","author":"Iversen","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib2","first-page":"35","article-title":"[3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites","volume":"26","author":"Javitch","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0024-3205(85)90204-8","article-title":"Quantitative autoradiography of 3H-nomifensine binding sites in rat brain","volume":"36","author":"Scatton","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/S0021-5198(19)43207-1_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1471-4159.1983.tb13666.x","article-title":"Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites","volume":"41","author":"Kennedy","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0006-2952(85)90486-1","article-title":"Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes","volume":"34","author":"Dubocovich","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(85)90724-1","article-title":"The surgical and chemical lesions on striatal [3H]threo-(\u00b1)-methylphenidate binding: correlation with [3H]-dopamine uptake","volume":"108","author":"Janowsky","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00501873","article-title":"Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and Parkinsons disease","volume":"329","author":"Schoemarker","year":"1985","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib8","first-page":"363","article-title":"1,4-Dialk(en)yl-piperazines as selective and very potent inhibitors of dopamine uptake","volume":"15","author":"van der Zee","year":"1980","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(84)90483-7","article-title":"Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake","volume":"103","author":"Heikkila","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(86)90050-6","article-title":"High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system","volume":"126","author":"Bonnet","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43207-1_bib11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1471-4159.1986.tb00649.x","article-title":"Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex","volume":"46","author":"Janowsky","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1471-4159.1975.tb04421.x","article-title":"Reserpine sensitivity of catecholamine metabolism in murine neuroblatoma clone N1E-115","volume":"25","author":"Breakfield","year":"1975","journal-title":"J. Neurochem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/S0021-5198(19)43207-1_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(86)91207-2","article-title":"[3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson\u2019s disease","volume":"377","author":"Nishino","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/S0021-5198(19)43207-1_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib16","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1471-4159.1987.tb05752.x","article-title":"Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex","volume":"48","author":"Andersen","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1471-4159.1987.tb02908.x","article-title":"[3H]GBR-1 2935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson\u2019s disease","volume":"49","author":"Janowsky","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/S0021-5198(19)43207-1_bib18","first-page":"21","article-title":"Basal ganglia disease","author":"Marsden","year":"1982","journal-title":"Lancet 2"},{"key":"10.1016\/S0021-5198(19)43207-1_bib19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/0006-2952(86)90451-X","article-title":"Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes","volume":"35","author":"Kimelberg","year":"1986","journal-title":"Biochem. Pharmacol."}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819432071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819432071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T13:09:03Z","timestamp":1618405743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819432071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"references-count":19,"aliases":["10.1254\/jjp.47.237"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988]]}},"alternative-id":["S0021519819432071"],"URL":"https:\/\/doi.org\/10.1016\/s0021-5198(19)43207-1","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1988]]}}}